share_log

Quince Therapeutics(QNCX.US) Director Buys US$107.9K in Common Stocks

moomoo News ·  Aug 31, 2023 22:16

$Quince Therapeutics (QNCX.US)$ Director Lamond David purchased 82,052 shares of Common Stocks on Aug 30, 31, 2023 at an average price of $1.32 for a total value of $107.9K.

1693524029378055373.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment